Biodelivery Sciences International Inc (BDSI) Inventory Turnover Ratio, from fourth quarter 2021 to fourth quarter 2020, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Biodelivery Sciences International Inc   (NASDAQ: BDSI)
 

Biodelivery Sciences International Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the fourth quarter 2021, Biodelivery Sciences International Inc 's inventory turnover ratio sequentially decreased to 1.13 in the fourth quarter 2021, unsurprisingly, as the Biodelivery Sciences International Inc markets continue to deteriorate, and BDSI's faces growing challenges to bring down its inventories. Biodelivery Sciences International Inc 's average inventory processing period in the Dec 31 2021 quarter, has increased to 323 days, from 281 days, in the Sep 30 2021 quarter.

Within Healthcare sector 365 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1961 in the third quarter 2021, to 1996.

BDSI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Biodelivery Sciences International Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BDSI Inventory Turnover Ratio (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter
Y / Y Inventory Growth 35.93 % 22.17 % 4.98 % 13.1 % 54.2 %
Y / Y Cost of Sales Growth -16.77 % 18.4 % -21.18 % 4.69 % 14.16 %
Inventory Turnover Ratio (TTM) 1.13 1.3 1.32 1.4 1.43
BDSI's Total Ranking # 1996 # 1961 # 1956 # 1938 # 1513
Average inventory processing period 322 281 276 260 256
Seq. Inventory Growth 2.76 % 23.67 % 9.97 % -2.72 % -7.65 %
Seq. Cost of Sales Growth 8.45 % 48.58 % -26.4 % -29.82 % 54.28 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 111
Healthcare Sector # 366
Overall Market # 1996

Inventory Turnover Ratio Statistics
High Average Low
4.36 2.54 1.13
(Sep 30 2015)   (Dec 31 2021)



BDSI Company Profile >> Back to BDSI Efficiency Comparisons >> Compare BDSI Inventory Turnover Ratio to its Competitors

Financial Statements
Biodelivery Sciences International Inc 's Inventories $ 24 Millions Visit BDSI's Balance sheet
Biodelivery Sciences International Inc 's Cost of Revenues TTM $ 23 Millions Visit BDSI's Income Statement
What are BDSI's Sales? Visit BDSI's Sales by Segment

Other Inventory Turnover Ratios
Biodelivery Sciences International Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BDSI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BDSI's Competitors
Inventory Turnover Ratio for BDSI's Suppliers
Inventory Turnover Ratio for BDSI's Customers

You may also want to know
BDSI's Sales Growth Rates BDSI's Pe Price to earnings ratio BDSI's Receivables Turnover Ratio BDSI's Stock Quote
BDSI's Net Income Growth Rates BDSI's Ps Price to Sales ratio BDSI's Sales per Employee BDSI's Asset Turnover Ratio
BDSI's Net Margin BDSI's Pb Price to Book ratio BDSI's Financial Strength Ratios BDSI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Dec 31 2021, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Dec 31 2021 Inventories at quarter ending Dec 31 2021
Allied Healthcare Products inc   2.71 $ 24.884  Millions$ 9  Millions
Neogen Corporation  2.69 $ 270.814  Millions$ 101  Millions
Adaptive Biotechnologies Corporation  2.68 $ 49.301  Millions$ 18  Millions
Zynex inc   2.68 $ 27.321  Millions$ 10  Millions
Apyx Medical Corp  2.65 $ 14.916  Millions$ 6  Millions
International Stem Cell Corporation  2.64 $ 2.935  Millions$ 1  Millions
Organon and Co   2.63 $ 2,382.000  Millions$ 907  Millions
Surmodics Inc   2.59 $ 17.931  Millions$ 7  Millions
Amneal Pharmaceuticals Inc   2.57 $ 1,302.004  Millions$ 508  Millions
Teleflex Incorporated  2.57 $ 1,259.961  Millions$ 491  Millions
Therapeuticsmd Inc   2.52 $ 18.838  Millions$ 7  Millions
Sanuwave Health Inc   2.51 $ 4.986  Millions$ 2  Millions
Neurometrix Inc   2.51 $ 2.332  Millions$ 1  Millions
Viveve Medical Inc   2.50 $ 5.806  Millions$ 2  Millions
Perrigo Company Plc  2.50 $ 2,722.500  Millions$ 1,091  Millions
Rayont Inc   2.49 $ 1.227  Millions$ 0  Millions
Boston Scientific Corporation  2.45 $ 3,711.000  Millions$ 1,513  Millions
Amphastar Pharmaceuticals Inc   2.45 $ 238.029  Millions$ 97  Millions
Dynavax Technologies Corporation  2.45 $ 173.572  Millions$ 71  Millions
Grapefruit Usa Inc   2.44 $ 1.119  Millions$ 0  Millions
Zeo Scientifix Inc   2.44 $ 0.529  Millions$ 0  Millions
Apollo Endosurgery inc   2.43 $ 26.576  Millions$ 11  Millions
Conformis inc   2.42 $ 34.179  Millions$ 14  Millions
Elite Pharmaceuticals Inc   2.40 $ 13.979  Millions$ 6  Millions
Femasys Inc   2.39 $ 0.426  Millions$ 0  Millions
Lifevantage Corp  2.39 $ 37.708  Millions$ 16  Millions
Orasure Technologies Inc  2.38 $ 116.074  Millions$ 49  Millions
Milestone Scientific Inc   2.38 $ 3.993  Millions$ 2  Millions
Enovis Corp  2.38 $ 1,430.498  Millions$ 602  Millions
Avanos Medical Inc   2.37 $ 381.300  Millions$ 161  Millions

Date modified: 2026-09-08T15:10:31+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.